Double Check Policy, LASA/High Alert warnings

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jgold@ismp.org

4 posts / 0 new
Last post
Erin Hudgens
Erin Hudgens's picture
Offline
Last seen: 2 weeks 17 hours ago
Joined: 10/02/2023 - 11:28
Double Check Policy, LASA/High Alert warnings

We've had a few issues rear up at my hospital recently. So, I have a couple of questions for the smartest group of people I know:

1) What type of notification process do you use at your facility when shortages occur? Do you have a Pharmacy bulletin or just coordinate with the specific affected department? Do you have any sort of formal policy? If anyone has something they could share, I'd be interested to read.

2) For those facilities using a CERNER EHR product, which medications are set up in your system to require a 2 person sign off or documentation for double check on the MAR? Does your facility require an independent double check for all medications, just high-alert medications, or only a selection of high-alert? And if so, which ones do you mandate an IDC for? Does anyone have a policy or procedure on this for your hospital that you teach at staff orientation?

3) For those facilities that use Pyxis, do you have the Clinical Data Categories activated for LASA and High Alert medications in all areas of the hospital? Are there any areas where these alerts are turned off (like OR, GI, General Surgery clinic, etc)?

Tags: